Advertisement

Subcutaneous Metastasis of Cancer of the Endometrium

  • Sahara ShurieEmail author
  • Loice Luhumyo
  • Elly Benjamin Odongo
  • Emmanuel Wekesa Wamalwa
  • Vincent Oyiengo
  • Keitany Kibor Kibet
  • Orang’o Elkanah Omenge
  • Hellen Muliro
Case Report
  • 20 Downloads

Abstract

Background

Cancer of the endometrium is the third most common gynecological malignancy after cancer of the cervix and ovary in Kenya. Subcutaneous metastasis is unusual site for endometrial cancer. Few cases of cutaneous and subcutaneous metastases from cancer of endometrium have been reported in the literature. The main areas of cutaneous and subcutaneous metastases are abdominal, perineal surfaces, skin and toes. Disseminated lesions are associated with hematogenous spread, while some occur via lymphatic spread or contiguity.

Case Presentation

We present a case of a 45-year-old female, Para 5 + 0, who presented to our gynecologic oncology clinic in July 2017. The patient was referred from a peripheral health facility for chemotherapy following radical hysterectomy in May 2017 for endometrial cancer. Histology results of the specimen taken during surgery showed endometrial Ca stage 2, grade 3. The patient developed a swelling on the right leg 6 months after completion of 6 cycles of carboplatin and paclitaxel. Biopsy from the leg showed features consistent with metastatic endometrioid adenocarcinoma. The patient was started on pegylated liposomal doxorubicin. Local radiation of the metastatic subcutaneous lesion was also done.

Conclusion

Cutaneous and subcutaneous metastases from cancer of the endometrium are rare. We recommend histologic evaluation of subcutaneous masses developing in patients with endometrial cancer or in those suspected to have endometrial cancer.

Notes

Compliance with Ethical Standards

Conflict of interest

The authors declare no conflict of interest.

Ethical Approval

The study was approved by the Moi University/Moi Teaching and Referral Hospital Institutional Research and Ethics Committee (IREC). The Approval Number is 0003167.

Informed Consent

A written informed consent was obtained from the patient (prior to her demise) before the study was conducted.

References

  1. 1.
    American Cancer Society. Key statistics for endometrial cancer. Retrieved August 29, 2018, from https://www.cancer.org/cancer/endometrial-cancer/about/key-statistics.html.
  2. 2.
    de Boer SM, Powell ME, Mileshkin L, Katsaros D, Bessette P, Haie-Meder C, Tubiana-Mathieu N, et al. Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial. Lancet Oncol. 2018;19(3):295–309.  https://doi.org/10.1016/S1470-2045(18)30079-2.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Hoffman BL, Schorge JO, Bradshaw KD, Halvorson LM, Schaffer JI, Corton MM. Williams gynecology. 3rd ed., AccessMedicine, McGraw-Hill Medical. 2010; https://accessmedicine.mhmedical.com/book.aspx?bookid=1758. Accessed 2010.
  4. 4.
    Arenas M, Gascón M, Rovirosa À, Hernández V, Riu F, López I, Sabater S, et al. The effect of lymphadenectomy and radiotherapy on recurrence and survival in endometrial carcinoma. Experience in a population reference centre. Reports of practical oncology and radiotherapy. J Greatpoland Cancer Cent Pozn Pol Soc Radiat Oncol. 2015;20(1):50–6.  https://doi.org/10.1016/j.rpor.2014.09.003.CrossRefGoogle Scholar
  5. 5.
    Finn WF. Time, site, and treatment of recurrences of endometrial carcinoma. Am J Obstet Gynecol. 1950;60(4):773–82.  https://doi.org/10.1016/S0002-9378(16)39102-5.CrossRefPubMedGoogle Scholar
  6. 6.
    El M’rabet F, Hottinger A, George A, Tille J, El mesbahi O, Castiglione-Gertsch M, Bodmer A. Cutaneous metastasis of endometrial carcinoma: a case report and literature review. J Clin Gynecol Obstet. 2012;1(1):19–23.Google Scholar
  7. 7.
    Krathen RA, Orengo IF, Rosen T. Cutaneous metastasis: a meta-analysis of data. South Med J. 2003;96(2):164–7.  https://doi.org/10.1097/01.SMJ.0000053676.73249.E5.CrossRefPubMedGoogle Scholar
  8. 8.
    Atallah D, el Kassis N, Lutfallah F, Safi J, Salameh C, Nadiri S, Bejjani L. Cutaneous metastasis in endometrial cancer: once in a blue moon—case report. World J Surg Oncol. 2014;12:86.  https://doi.org/10.1186/1477-7819-12-86.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Baydar M, Dikilitas M, Sevinc A, Senel S, Senel F, Aydogdu I. Cutaneous metastasis of endometrial carcinoma with hemorrhagic nodules and papules. Eur J Gynaecol Oncol. 2005;26(4):464–5.PubMedGoogle Scholar
  10. 10.
    Giardina VN, Morton BF, Potter GK, Mesa-Tejada R, Waterfield WC. Metastatic endometrial adenocarcinoma to the skin of a toe. Am J Dermatopathol. 1996;18(1):94–8.CrossRefGoogle Scholar
  11. 11.
    Bacalbasa N, Balescu I, Filipescu A. Subcutaneous metastasis from endometrial cancer; case report and literature review. J Clin Invest Surg. 2018;3(1):37–41.CrossRefGoogle Scholar
  12. 12.
    Elit L, Lukka H, Friedman E. Cutaneous metastasis of papillary serous uterine cancer. Gynecol Oncol. 2001;82(1):208–11.  https://doi.org/10.1006/gyno.2001.6224.CrossRefPubMedGoogle Scholar
  13. 13.
    Chang ES, Baker WD, Landen CN. Metastatic papillary serous uterine cancer presenting as a rash. Gynecol Oncol Rep. 2016;18:11–3.  https://doi.org/10.1016/j.gore.2016.09.001.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Kanyilmaz G, Aktan M, Koc M, Findik S. Cutaneous metastases of the synchronous primary endometrial and bilateral ovarian cancer: an infrequent presentation and literature review. Case Rep Oncol Med. 2016;2016:4568653.  https://doi.org/10.1155/2016/4568653.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Bassir BA, Boukhanni L, Kouchani M, Belabidia B, Asmouki H, Soummani A. Cutaneous metastasis from endometrial adenocarcinoma: case report and literature review. Webmed Cent Obstet Gynaecol. 2012;3(9):WMC003723.Google Scholar
  16. 16.
    Kubicek GJ, Xue J, Xu Q, Asbell SO, Hughes L, Kramer N, LaCouture T. Stereotactic body radiotherapy as an alternative to brachytherapy in gynecologic cancer. BioMed Res Int. 2013.  https://doi.org/10.1155/2013/898953.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Deodato F, Macchia G, Grimaldi L, Ferrandina G, Lorusso D, Salutari V, Morganti AG. Stereotactic radiotherapy in recurrent gynecological cancer: a case series. Oncol Rep. 2009;22(2):415–9.PubMedGoogle Scholar
  18. 18.
    Guckenberger M, Bachmann J, Wulf J, Mueller G, Krieger T, Baier K, Flentje M. Stereotactic body radiotherapy for local boost irradiation in unfavourable locally recurrent gynaecological cancer. Radiother Oncol. 2010;94(1):53–9.  https://doi.org/10.1016/j.radonc.2009.12.004.CrossRefPubMedGoogle Scholar

Copyright information

© Association of Gynecologic Oncologists of India 2019

Authors and Affiliations

  1. 1.Department of Reproductive Health, School of MedicineMoi UniversityEldoretKenya
  2. 2.Faculty of Health SciencesEgerton UniversityNakuruKenya
  3. 3.Moi Teaching and Referral HospitalEldoretKenya
  4. 4.AMPATH Oncology InstituteEldoretKenya

Personalised recommendations